Cetera Advisor Networks’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,277
Closed -$114K 2842
2023
Q4
$114K Buy
+11,277
New +$99K ﹤0.01% 2631
2022
Q3
Sell
-10,391
Closed -$123K 2112
2022
Q2
$123K Buy
+10,391
New +$139K ﹤0.01% 1932
2021
Q4
Sell
-8,667
Closed -$356K 2058
2021
Q3
$356K Buy
8,667
+671
+8% +$36.8K ﹤0.01% 1421
2021
Q2
$453K Sell
7,996
-5,866
-42% -$217K 0.01% 1231
2021
Q1
$582K Buy
13,862
+9,056
+188% +$516K 0.01% 805
2020
Q4
$337K Buy
+4,806
New +$197K 0.01% 982
2020
Q3
Sell
-2,518
Closed -$74K 1692
2020
Q2
$74K Buy
+2,518
New +$65.8K ﹤0.01% 1689

Other funds holding EDIT

Cetera Advisor Networks's EDIT Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 11,277 shares — an estimated $114K sold.

Cetera Advisor Networks first reported a position in EDIT in Q2 2020 and held it in 7 quarters. The position peaked at $582K in Q1 2021. 226 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 11,277 Editas Medicine shares in Q1 2024, an estimated $114K.
  • Cetera Advisor Networks first reported a position in Editas Medicine in Q2 2020 and held it in 7 quarters.
  • Cetera Advisor Networks's Editas Medicine position peaked at $582K in Q1 2021.
  • 226 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.